id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-1192-0004,FDA,FDA-2021-N-1192,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2022-08-22T04:00:00Z,2022,8,2022-08-22T04:00:00Z,,2022-08-22T13:36:51Z,2022-18062,0,0,0900006485261393
FDA-2021-N-1192-0003,FDA,FDA-2021-N-1192,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Generally Recognized as Safe: Notification Procedure,Notice,30 Day Proposed Information Collection,2022-06-08T04:00:00Z,2022,6,2022-06-08T04:00:00Z,2022-07-09T03:59:59Z,2022-06-08T14:06:44Z,2022-12367,0,0,090000648514d1f7
FDA-2021-N-1192-0001,FDA,FDA-2021-N-1192,Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Generally Recognized as Safe: Notification Procedure,Notice,60 Day Proposed Information Collection,2021-11-19T05:00:00Z,2021,11,2021-11-19T05:00:00Z,2022-01-19T04:59:59Z,2022-01-19T02:00:28Z,2021-25302,0,0,0900006484e655f6